Inhibition of local and systemic inflammatory responses by POLB 001, a novel p38 MAPK inhibitor, following in vivo LPS administration in healthy volunteers
Inhibition of local and systemic inflammatory responses by POLB 001, a novel p38 MAPK inhibitor, following in vivo LPS administration in healthy volunteers
D.T. de Bruin, M.A.A. Jansen, J. Skillington, L. Tremble, S. Rajbally, N.B. Klarenbeek, M. Moerland...
POLB 001, an Oral Broad-Spectrum Anti-Inflammatory with the Potential to Prevent Cytokine Release Syndrome (CRS)
POLB 001, an Oral Broad-Spectrum Anti-Inflammatory with the Potential to Prevent Cytokine Release Syndrome (CRS)
E. Searle, L.F. Tremble, R. Popat, D.T. de Bruin, M. Moerland, B. Buckley...